Evogene Schedules First Quarter 2025 Financial Results Release - Stock Titan
Yesterday • Google News
Evogene (EVGN)
US$ 1.440.7%
Price Chart
Key Statistics
Market Cap
$ 7.87M
P/E Ratio
0.00
Revenue (TTM)
$ 8.51M
Volume
17.05K
52W High
$ 9.00
52W Low
$ 0.95
Dividend Yield
0.00%
Beta
1.18
Technicals
50-Day MA
1.2688
200-Day MA
2.2401
52 Week High
8.996
52 Week Low
0.95
About EVGN
Evogene Ltd., together with its subsidiaries, operates as a computational biology company in Israel, the United States, Israel, Brazil, and internationally.
Employees
117
Headquarters
Rehovot, Israel
CEO
Mr. Ofer Haviv CPA
Latest News
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - PR Newswire
3 weeks ago • Google News
Why Evogene Ltd. (EVGN) Soared on Monday - Yahoo Finance
3 weeks ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg